
Tiffany Maureen Gough
Examiner (ID: 2776, Phone: (571)272-0697 , Office: P/1651 )
| Most Active Art Unit | 1651 |
| Art Unit(s) | 1651, 1657 |
| Total Applications | 682 |
| Issued Applications | 174 |
| Pending Applications | 102 |
| Abandoned Applications | 426 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 20231302
[patent_doc_number] => 20250288621
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-09-18
[patent_title] => USE OF AKKERMANSIA FOR TREATING METABOLIC DISORDERS
[patent_app_type] => utility
[patent_app_number] => 19/224021
[patent_app_country] => US
[patent_app_date] => 2025-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9534
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19224021
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/224021 | USE OF AKKERMANSIA FOR TREATING METABOLIC DISORDERS | May 29, 2025 | Pending |
Array
(
[id] => 20231303
[patent_doc_number] => 20250288622
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-09-18
[patent_title] => USE OF AKKERMANSIA FOR TREATING METABOLIC DISORDERS
[patent_app_type] => utility
[patent_app_number] => 19/224071
[patent_app_country] => US
[patent_app_date] => 2025-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8617
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19224071
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/224071 | USE OF AKKERMANSIA FOR TREATING METABOLIC DISORDERS | May 29, 2025 | Pending |
Array
(
[id] => 20231303
[patent_doc_number] => 20250288622
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-09-18
[patent_title] => USE OF AKKERMANSIA FOR TREATING METABOLIC DISORDERS
[patent_app_type] => utility
[patent_app_number] => 19/224071
[patent_app_country] => US
[patent_app_date] => 2025-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8617
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19224071
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/224071 | USE OF AKKERMANSIA FOR TREATING METABOLIC DISORDERS | May 29, 2025 | Pending |
Array
(
[id] => 19616511
[patent_doc_number] => 20240402191
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-12-05
[patent_title] => IVALTINOSTAT COMBINATION THERAPY FOR TREATING PANCREATIC CANCER
[patent_app_type] => utility
[patent_app_number] => 18/657510
[patent_app_country] => US
[patent_app_date] => 2024-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10591
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -32
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18657510
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/657510 | IVALTINOSTAT COMBINATION THERAPY FOR TREATING PANCREATIC CANCER | May 6, 2024 | Pending |
Array
(
[id] => 19189112
[patent_doc_number] => 20240168025
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-23
[patent_title] => HEMATOPOIETIC CELL PHENOTYPING USING CIRCULATING CELL-FREE MARKERS
[patent_app_type] => utility
[patent_app_number] => 18/520470
[patent_app_country] => US
[patent_app_date] => 2023-11-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8681
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18520470
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/520470 | HEMATOPOIETIC CELL PHENOTYPING USING CIRCULATING CELL-FREE MARKERS | Nov 26, 2023 | Pending |
Array
(
[id] => 19050899
[patent_doc_number] => 20240092868
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-21
[patent_title] => METHOD, COMPOSITION, AND ARTICLE OF MANUFACTURE FOR PROVIDING ALPHA-1 ANTITRYPSIN
[patent_app_type] => utility
[patent_app_number] => 18/518341
[patent_app_country] => US
[patent_app_date] => 2023-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7332
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 117
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18518341
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/518341 | METHOD, COMPOSITION, AND ARTICLE OF MANUFACTURE FOR PROVIDING ALPHA-1 ANTITRYPSIN | Nov 21, 2023 | Pending |
Array
(
[id] => 19035466
[patent_doc_number] => 20240085281
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-14
[patent_title] => HISTOLOGICAL SPECIMEN TREATMENT
[patent_app_type] => utility
[patent_app_number] => 18/513343
[patent_app_country] => US
[patent_app_date] => 2023-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9892
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18513343
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/513343 | HISTOLOGICAL SPECIMEN TREATMENT | Nov 16, 2023 | Pending |
Array
(
[id] => 19186273
[patent_doc_number] => 20240165186
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-23
[patent_title] => Synergistically Formulated Compound for Mitochondria Supplementation and Enhancement
[patent_app_type] => utility
[patent_app_number] => 18/506182
[patent_app_country] => US
[patent_app_date] => 2023-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5844
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18506182
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/506182 | Synergistically Formulated Compound for Mitochondria Supplementation and Enhancement | Nov 9, 2023 | Pending |
Array
(
[id] => 19186273
[patent_doc_number] => 20240165186
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-23
[patent_title] => Synergistically Formulated Compound for Mitochondria Supplementation and Enhancement
[patent_app_type] => utility
[patent_app_number] => 18/506182
[patent_app_country] => US
[patent_app_date] => 2023-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5844
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18506182
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/506182 | Synergistically Formulated Compound for Mitochondria Supplementation and Enhancement | Nov 9, 2023 | Pending |
Array
(
[id] => 18841666
[patent_doc_number] => 20230404069
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-21
[patent_title] => CRYOPRESERVING UNGULATE EMBRYOS
[patent_app_type] => utility
[patent_app_number] => 18/360627
[patent_app_country] => US
[patent_app_date] => 2023-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12225
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 422
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18360627
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/360627 | CRYOPRESERVING UNGULATE EMBRYOS | Jul 26, 2023 | Pending |
Array
(
[id] => 18841666
[patent_doc_number] => 20230404069
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-21
[patent_title] => CRYOPRESERVING UNGULATE EMBRYOS
[patent_app_type] => utility
[patent_app_number] => 18/360627
[patent_app_country] => US
[patent_app_date] => 2023-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12225
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 422
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18360627
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/360627 | CRYOPRESERVING UNGULATE EMBRYOS | Jul 26, 2023 | Pending |
Array
(
[id] => 18862285
[patent_doc_number] => 20230416721
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-28
[patent_title] => COMBINATION THERAPEUTICS USING TUMOR TREATING FIELDS (TTFIELDS)
[patent_app_type] => utility
[patent_app_number] => 18/220864
[patent_app_country] => US
[patent_app_date] => 2023-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6516
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18220864
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/220864 | COMBINATION THERAPEUTICS USING TUMOR TREATING FIELDS (TTFIELDS) | Jul 11, 2023 | Pending |
Array
(
[id] => 20129417
[patent_doc_number] => 12371721
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-07-29
[patent_title] => Methods of recovering oil from microorganisms
[patent_app_type] => utility
[patent_app_number] => 18/220975
[patent_app_country] => US
[patent_app_date] => 2023-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 11
[patent_no_of_words] => 4776
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 99
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18220975
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/220975 | Methods of recovering oil from microorganisms | Jul 11, 2023 | Issued |
Array
(
[id] => 18707578
[patent_doc_number] => 20230330155
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-19
[patent_title] => FOLLICULAR FLUID METHOD
[patent_app_type] => utility
[patent_app_number] => 18/338963
[patent_app_country] => US
[patent_app_date] => 2023-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2313
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18338963
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/338963 | FOLLICULAR FLUID METHOD | Jun 20, 2023 | Abandoned |
Array
(
[id] => 18707578
[patent_doc_number] => 20230330155
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-19
[patent_title] => FOLLICULAR FLUID METHOD
[patent_app_type] => utility
[patent_app_number] => 18/338963
[patent_app_country] => US
[patent_app_date] => 2023-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2313
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18338963
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/338963 | FOLLICULAR FLUID METHOD | Jun 20, 2023 | Abandoned |
Array
(
[id] => 18538750
[patent_doc_number] => 20230243856
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-03
[patent_title] => IDENTIFYING DIRECT ORAL FACTOR XA INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 18/098422
[patent_app_country] => US
[patent_app_date] => 2023-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4249
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18098422
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/098422 | IDENTIFYING DIRECT ORAL FACTOR XA INHIBITORS | Jan 17, 2023 | Pending |
Array
(
[id] => 18597534
[patent_doc_number] => 20230272330
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-31
[patent_title] => EVALUATION SYSTEM AND EVALUATION METHOD
[patent_app_type] => utility
[patent_app_number] => 18/081147
[patent_app_country] => US
[patent_app_date] => 2022-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3813
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18081147
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/081147 | EVALUATION SYSTEM AND EVALUATION METHOD | Dec 13, 2022 | Pending |
Array
(
[id] => 18597534
[patent_doc_number] => 20230272330
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-31
[patent_title] => EVALUATION SYSTEM AND EVALUATION METHOD
[patent_app_type] => utility
[patent_app_number] => 18/081147
[patent_app_country] => US
[patent_app_date] => 2022-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3813
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18081147
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/081147 | EVALUATION SYSTEM AND EVALUATION METHOD | Dec 13, 2022 | Pending |
Array
(
[id] => 18325362
[patent_doc_number] => 20230123490
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-20
[patent_title] => COMPOSITIONS COMPRISING YEAST CELLS AND POLYPHENOLS AND THEIR USE
[patent_app_type] => utility
[patent_app_number] => 18/062612
[patent_app_country] => US
[patent_app_date] => 2022-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8645
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18062612
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/062612 | COMPOSITIONS COMPRISING YEAST CELLS AND POLYPHENOLS AND THEIR USE | Dec 6, 2022 | Abandoned |
Array
(
[id] => 18271920
[patent_doc_number] => 20230093162
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-23
[patent_title] => FATTY LIVER AND LIVER FIBROSIS EVALUATION SYSTEM BASED ON IMPEDANCE
[patent_app_type] => utility
[patent_app_number] => 18/070401
[patent_app_country] => US
[patent_app_date] => 2022-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6103
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 191
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18070401
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/070401 | FATTY LIVER AND LIVER FIBROSIS EVALUATION SYSTEM BASED ON IMPEDANCE | Nov 27, 2022 | Pending |